Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,321 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Completed

TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz

NCT00023413

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations
  • Central Arkansas Veterans Health System Little Rock, Arkansas, United States
  • LA County/USC Medical Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Denver Department of Public Health and Hospitals Denver, Colorado, United States
View all 23 locations
View Trial Details
Completed

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

NCT00000870

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
View all 20 locations
View Trial Details
Completed

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 60 locations
View Trial Details
Completed

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

NCT00000923

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
  • Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States
View Trial Details
Completed

Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen

NCT00000903

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 50 locations
View Trial Details
Completed

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

NCT00000918

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • Willow Clinic Menlo Park, California, United States
View all 39 locations
View Trial Details

Related conditions